Current management of chemotherapy-induced neutropenia in adults: key points and new challenges
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Current management of chemotherapy-induced neutropenia in adults: key points and new challenges have?
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges has 95 citations in the OpenAlex counts ScholarIQ stores.
When was Current management of chemotherapy-induced neutropenia in adults: key points and new challenges published?
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges has 2020 year in the ScholarIQ index.
What is the open-access status of Current management of chemotherapy-induced neutropenia in adults: key points and new challenges?
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges has gold oa status in the ScholarIQ index.
What is the DOI of Current management of chemotherapy-induced neutropenia in adults: key points and new challenges?
The DOI for Current management of chemotherapy-induced neutropenia in adults: key points and new challenges is on the source record.
What is the PMID of Current management of chemotherapy-induced neutropenia in adults: key points and new challenges?
The PMID for Current management of chemotherapy-induced neutropenia in adults: key points and new challenges is on the source record.
What is the OpenAlex record for Current management of chemotherapy-induced neutropenia in adults: key points and new challenges?
The OpenAlex for Current management of chemotherapy-induced neutropenia in adults: key points and new challenges is on the source record.